Piezo Therapeutics, founded in 2022 and headquartered in Atlanta, Georgia, specializes in advanced drug delivery technologies. The company's core mission is to revolutionize nucleic acid delivery through a proprietary platform that utilizes electric pulses and microneedles. This innovative approach aims to replace traditional lipid nanoparticles, offering safe and effective RNA/DNA delivery, cost-effective and scalable manufacturing, and durable expression for large or complex cargos. The platform is designed for simple administration by minimally trained personnel and is ultralow-cost and disposable, suitable for both single-use and repeated use.

Notable figures associated with Piezo Therapeutics include leading scientists and industry experts who have contributed to the development of its groundbreaking platform. The company has attracted significant interest from investors focused on cutting-edge biotechnologies. Key achievements include the successful demonstration of their platform's efficacy in delivering nucleic acids without the need for extensive screening processes. Piezo Therapeutics' impact lies in its potential to transform the landscape of drug delivery, making advanced therapies more accessible and affordable on a global scale.